Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer

被引:82
作者
Egloff, AM
Vella, LA
Finn, OJ
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA
关键词
D O I
10.1158/0008-5472.CAN-05-3389
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uncontrolled cell division is an indispensable event in tumor progression, and numerous molecules involved in this process have been the focus of intense investigation in tumor biology. Cyclins, molecules that orchestrate normal cell cycle progression, are abnormally overexpressed in various human cancers. We review evidence that the immune system recognizes some abnormally expressed cyclins as tumor antigens, such as cyclin B1, and we analyze the potential of cyclins D, E, and A to serve a similar function in cancer immunosurveillance.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 20 条
[1]   Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer [J].
Betticher, DC ;
Heighway, J ;
Hasleton, PS ;
Altermatt, HJ ;
Ryder, WDJ ;
Cerny, T ;
Thatcher, N .
BRITISH JOURNAL OF CANCER, 1996, 73 (03) :294-300
[2]  
Covini G, 1997, HEPATOLOGY, V25, P75
[3]   Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer [J].
Egloff, AM ;
Weissfeld, J ;
Land, SR ;
Finn, OJ .
HUMAN IMMUNOLOGY: PATIENT-BASED RESEARCH, 2005, 1062 :29-40
[4]   Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome [J].
Ekberg, J ;
Holm, C ;
Jalili, S ;
Richter, J ;
Anagnostaki, L ;
Landberg, G ;
Persson, JL .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (02) :106-115
[5]  
GRAZIANO DF, 2004, TUMOR IMMUNOLOGY CAN, P89
[6]  
Harwell RM, 2000, CANCER RES, V60, P481
[7]   Cyclin E in normal and neoplastic cell cycles [J].
Hwang, HC ;
Clurman, BE .
ONCOGENE, 2005, 24 (17) :2776-2786
[8]  
Juan G, 2001, CANCER RES, V61, P1220
[9]   Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells [J].
Kao, H ;
Marto, JA ;
Hoffman, TK ;
Shabanowitz, J ;
Finkelstein, SD ;
Whiteside, TL ;
Hunt, DF ;
Finn, OJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1313-1323
[10]   Cellular immunity to the Her-2/neu protooncogene [J].
Kiessling, R ;
Wei, WZ ;
Herrmann, F ;
Lindencrona, JA ;
Choudhury, A ;
Kono, K ;
Seliger, B .
ADVANCES IN CANCER RESEARCH, VOL 85, 2002, 85 :101-144